167 related articles for article (PubMed ID: 2521960)
1. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
McGonigle P; Boyson SJ; Reuter S; Molinoff PB
Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
[TBL] [Abstract][Full Text] [Related]
4. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
5. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
Wamsley JK; Gehlert DR; Filloux FM; Dawson TM
J Chem Neuroanat; 1989; 2(3):119-37. PubMed ID: 2528968
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
9. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
10. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
11. Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals.
Filloux F; Liu TH; Hsu CY; Hunt MA; Wamsley JK
Synapse; 1988; 2(5):521-31. PubMed ID: 2973146
[TBL] [Abstract][Full Text] [Related]
12. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
Beckstead RM; Wooten GF; Trugman JM
J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
[TBL] [Abstract][Full Text] [Related]
13. Comparative distributions of dopamine D-1 and D-2 receptors in the cerebral cortex of rats, cats, and monkeys.
Richfield EK; Young AB; Penney JB
J Comp Neurol; 1989 Aug; 286(4):409-26. PubMed ID: 2506254
[TBL] [Abstract][Full Text] [Related]
14. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
15. In vivo binding of SCH 39166: a D-1 selective antagonist.
McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
Hietala J; Syvälahti E; Röyttä M
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
[TBL] [Abstract][Full Text] [Related]
17. [The effects of dopamine D-1 and D-2 receptor antagonists on 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum with differential normal pulse voltammetry].
Wang X; Niu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Aug; 14(4):257-62. PubMed ID: 1473213
[TBL] [Abstract][Full Text] [Related]
18. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
Lau YS; Runice C; Dowd F
J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
[TBL] [Abstract][Full Text] [Related]
19. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor changes in response to prolonged treatment with L-dopa.
Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
